The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

DINAJPUR, April 30, 2026 (BSS) - For the first time in Dinajpur, a Cardiac Resynchronization Therapy (CRT) device has been ...

Columbus Regional Health is pleased to offer the OmniaSecure™ defibrillation lead, a novel advancement in transvenous ...

Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

Electrophysiologists at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin recently became the first in the U.S. to implant an FDA-approved leadless system for cardiac ...

A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...

A Florida hospital has developed a system for wireless real-time monitoring and reprogramming of cardiac devices, including pacemakers and defibrillators, using an iPad. A doctor can suggest changes ...

Future Cardia, a medical device company, announced an expanded collaboration with remote cardiac monitoring company, Artella Solutions. Future Cardia is developing an implantable cardiac monitoring ...

SAN DIEGO, CA—The observational BIO-LIBRA study, which enrolled nearly 50% women, has revealed important outcome differences by both sex and device type among patients with nonischemic cardiomyopathy ...